| Trial ID: | L0892 |
| Source ID: | NCT01815892
|
| Associated Drug: |
Withdrawal Of Furosemide
|
| Title: |
The Use of Furosemide in Patients on Dialysis
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: Withdrawal of furosemide|DRUG: furosemide administration
|
| Outcome Measures: |
Primary: 24 hour urine sodium and water excretion, The patients 24 hour sodium and water excretion on and off the medication (which they had already been taking) will be compared for effectiveness of the drug. The hypothesis is that the urine sodium concentration off the drug, will predict the response and thus be of diagnostic value for other patients, 2 weeks | Secondary: Interdialytic weight gain, The interdialytic weight gain on and off the drug will be compared, 2 weeks | Other: The patients' BP on and off the drug will be compared, The patients pre dialysis BP as well as the 48 hr ambulatory BP (if the patient is willing) will be compared in both phases of the study., 2 weeks
|
| Sponsor/Collaborators: |
Sponsor: Unity Health Toronto
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
51
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2015-05
|
| Completion Date: |
2016-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-08-10
|
| Locations: |
St Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT01815892
|
